Lisinopril vs losartan for hypertension
Pro Research Analysisby 
Searched over 200M research papers
Antihypertensive Effectiveness: Lisinopril vs Losartan
Several studies have directly compared lisinopril, an ACE inhibitor, and losartan, an angiotensin receptor blocker (ARB), for blood pressure (BP) control in patients with hypertension. Research shows that both drugs significantly lower systolic and diastolic BP, but some studies found lisinopril to be more effective than losartan in reducing BP, especially when measured at home or with ambulatory monitoring rather than in the clinic setting Stergiou2003Stergiou2002. However, other studies found no significant difference in the proportion of patients reaching target BP between the two drugs, suggesting similar overall efficacy in many cases .
Blood Pressure Control Patterns and Duration
Lisinopril has been shown to provide a more consistent antihypertensive effect throughout the day, as indicated by higher trough-to-peak ratios and morning-to-evening BP ratios compared to losartan . This suggests lisinopril may offer more stable BP control over a 24-hour period.
Combination Therapy and Dose Adjustments
For patients whose hypertension is not controlled by lisinopril alone, adding losartan to lisinopril therapy results in a greater reduction in BP than simply doubling the lisinopril dose, indicating a potential benefit of combination therapy for more complete renin-angiotensin system (RAS) blockade . In patients with proteinuric nephropathies, combining losartan with lisinopril or increasing the losartan dose both improved BP and proteinuria, but the combination was slightly more effective in those with high baseline proteinuria, though higher doses of losartan were better tolerated .
Effects on Myocardial Perfusion and Insulin Sensitivity
Lisinopril, but not losartan, has been shown to improve myocardial perfusion reserve in patients with hypertension and left ventricular hypertrophy, suggesting a possible advantage for lisinopril in repairing coronary microvascular function . Additionally, lisinopril improved insulin sensitivity in non-diabetic hypertensive patients, while losartan did not have a significant effect on this parameter .
Safety and Tolerability
Both drugs are generally well tolerated, but lisinopril is associated with a higher incidence of cough, while losartan tends to have fewer side effects overall . Twice-daily dosing of either drug does not appear to offer additional BP-lowering benefits compared to once-daily dosing, and higher doses of lisinopril may increase the risk of angioedema .
Mechanistic Insights from Animal Studies
Animal studies confirm that both lisinopril and losartan lower BP by acting on the RAS, but lisinopril may have a stronger effect in certain genetic models of hypertension Moriguchi1994Jessup2006. Both drugs also influence the expression of RAS-related enzymes and peptides, but with some differences in their impact on angiotensin II and angiotensin-(1-7) levels .
Conclusion
Lisinopril and losartan are both effective for treating hypertension, with some evidence suggesting lisinopril may provide more consistent BP control and additional benefits for myocardial perfusion and insulin sensitivity. Losartan, however, is often better tolerated with fewer side effects. Combination therapy or dose adjustments may be considered for patients with resistant hypertension or proteinuria. The choice between these medications should be individualized based on patient characteristics, comorbidities, and tolerability.
Sources and full results
Most relevant research papers on this topic